Sugi Predict

Sugi Predict / Compounds / SCHEMBL6282491

SCHEMBL6282491

SCHEMBL6282491

CN(C)CC(O)c1ccccn1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.68
▸ CHRM2 P08172 5/20 0.54
▸ SLC6A2 P23975 5/20 0.54
▸ SLC6A4 P31645 5/20 0.54
▸ SCN1A P35498 3/20 0.54
▸ SCN2A Q99250 3/20 0.54
▸ SCN3A Q9NY46 3/20 0.54
▸ LMNA P02545 2/20 0.48
▸ CYP2C19 P33261 2/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ KCNH2 Q12809 5/20 0.48
▸ CHRM1 P11229 4/20 0.48
▸ HRH1 P35367 4/20 0.48
▸ SLC6A3 Q01959 4/20 0.48
▸ HRH3 Q9Y5N1 4/20 0.48
▸ KCNA5 P22460 4/20 0.48
▸ ADRA2B P18089 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1205713 1.00 TSHR (0.68) TSHRCHRM2SLC6A2SLC6A4SCN1A
SCHEMBL6282488 0.87 TSHR (0.56) TSHRCHRM2SLC6A2SLC6A4SCN1A
SCHEMBL6324877 0.87 TSHR (0.56) TSHRCHRM2SLC6A2SLC6A4SCN1A
SCHEMBL6320631 0.87 TSHR (0.56) TSHRCHRM2SLC6A2SLC6A4SCN1A
SCHEMBL25159691 0.80 TSHR (0.49) TSHRCHRM2SLC6A2SLC6A4SCN1A
SCHEMBL506917 0.80 KCNA5 (0.52) TSHRCHRM2SLC6A2SLC6A4SCN1A
SCHEMBL29767197 0.80 KCNA5 (0.52) TSHRCHRM2SLC6A2SLC6A4SCN1A
SCHEMBL7268370 0.80 KCNA5 (0.52) TSHRCHRM2SLC6A2SLC6A4SCN1A
SCHEMBL31744336 0.80 KCNA5 (0.52) TSHRCHRM2SLC6A2SLC6A4SCN1A
Hydrochloric Acid SCHEMBL30887852 0.79 KCNA5 (0.50) TSHRCHRM2SLC6A2SLC6A4SCN1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6861438-B2 Antiviral agents PFIZER (US) 2005-03-01 — — US claimed
US-6852731-B2 Antiviral compounds PFIZER (US) 2005-02-08 — — US claimed
US-20040242884-A1 ANTIVIRAL COMPOUNDS PHARMACIA & UPJOHN COMPANY 2004-12-02 — — US claimed
US-20040138449-A1 Antiviral agents PHARMACIA & UPJOHN COMPANY 2004-07-15 — — US claimed
US-20190046515-A1 AMIDO THIADIAZOLE DERIVATIVES AS NADPH OXIDASE INHIBITORS GENKYOTEX SA (CH) 2019-02-14 — — US disclosed
US-20190046515-A1 AMIDO THIADIAZOLE DERIVATIVES AS NADPH OXIDASE INHIBITORS GENKYOTEX SA (CH) 2019-02-14 — — US disclosed
US-10130619-B2 Amido thiadiazole derivatives as NADPH oxidase inhibitors GENKYOTEX SUISSE SA (CH) 2018-11-20 — — US disclosed
US-20170348296-A1 AMIDO THIADIAZOLE DERIVATIVES AS NADPH OXIDASE INHIBITORS GENKYOTEX SUISSE SA (CH) 2017-12-07 — — US disclosed
US-20170348296-A1 AMIDO THIADIAZOLE DERIVATIVES AS NADPH OXIDASE INHIBITORS GENKYOTEX SUISSE SA (CH) 2017-12-07 — — US disclosed
US-20170348296-A1 AMIDO THIADIAZOLE DERIVATIVES AS NADPH OXIDASE INHIBITORS GENKYOTEX SUISSE SA (CH) 2017-12-07 — — US disclosed
EP-3233847-A1 AMIDO THIADIAZOLE DERIVATIVES AS NADPH OXIDASE INHIBITORS GenKyoTex Suisse SA (CH) 2017-10-25 — — EP disclosed
WO-2016098005-A1 AMIDO THIADIAZOLE DERIVATIVES AS NADPH OXIDASE INHIBITORS GENKYOTEX SA (CH) 2016-06-23 — — WO disclosed
US-6878705-B2 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide antiviral agents PFIZER (US) 2005-04-12 — — US disclosed
US-6861438-B2 Antiviral agents PFIZER (US) 2005-03-01 — — US disclosed
US-6852731-B2 Antiviral compounds PFIZER (US) 2005-02-08 — — US disclosed
US-20040259907-A1 4-OXO-4,7-DIHYDROFURO[2,3-B]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY 2004-12-23 — — US disclosed
US-20040242884-A1 ANTIVIRAL COMPOUNDS PHARMACIA & UPJOHN COMPANY 2004-12-02 — — US disclosed
EP-1465895-A2 4-OXO-4,7-DIHYDROFURO(2,3-B)PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 2004-10-13 — — EP disclosed
US-20040138449-A1 Antiviral agents PHARMACIA & UPJOHN COMPANY 2004-07-15 — — US disclosed
WO-2003059911-A2 4-OXO-4, 7-DIHYDROFURO[2,3-b]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 2003-07-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170348296-A1 AMIDO THIADIAZOLE DERIVATIVES AS NADPH OXIDASE INHIBITORS NOX1, NOX5, CYBB TSHR 2599/4885CHRM2 2588/4885SLC6A2 2373/4885
US-20040259907-A1 4-OXO-4,7-DIHYDROFURO[2,3-B]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS IL4, ZC3HAV1, IRF3 TSHR 3637/4885CHRM2 4620/4885SLC6A2 4331/4885
US-20040242884-A1 ANTIVIRAL COMPOUNDS ZC3HAV1, IRF3, IFNAR1 TSHR 3688/4885CHRM2 4608/4885SLC6A2 1762/4885
US-20040138449-A1 Antiviral agents IRF3, IFNAR1, EIF2AK2 TSHR 2937/4885CHRM2 4372/4885SLC6A2 2641/4885
US-20190046515-A1 AMIDO THIADIAZOLE DERIVATIVES AS NADPH OXIDASE INHIBITORS NOX1, NOX5, CYBB TSHR 2599/4885CHRM2 2588/4885SLC6A2 2373/4885
US-10130619-B2 Amido thiadiazole derivatives as NADPH oxidase inhibitors NOX1, NOX5, CYBB TSHR 2599/4885CHRM2 2588/4885SLC6A2 2373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.